Epitalon and telomere maintenance in cells
Normal human cells and breast cancer cells; no patients
What did they want to find out?
Does Epitalon change the ends of DNA in cells?
What did researchers observe?
Telomere length and the pathways used to maintain it changed.
What does this mean for you?
This is a biological clue, not a health outcome in people.
What we still do not know
Cell types had different exposures. No proof of rejuvenation or clinical cancer safety; figures corrected in 2025.
Show study details
Original sources checked on 4 October 2026. AI-assisted editorial summaries, not a systematic review or an independent medical assessment.
Epitalon and telomere maintenance in cells
Biogerontology · 2025
How it was studied
Laboratory experiment in cultured cells. Normal human cells and breast cancer cells; no patients.
Study finding
Telomere length and the pathways used to maintain it changed.
Study limitations
Cell types had different exposures. No proof of rejuvenation or clinical cancer safety; figures corrected in 2025.
Who is behind the study?
- Identified authors
- Sarah Al-dulaimi, Ross Thomas, Sheila Matta, Terry Roberts
- Funding and involvement
- Self-funded students and Brunel's Biosciences Department.
- Disclosed interests and verification limits
- Authors declare no conflicts; Peptides of London donated material and UK Peptides is named as a supplier.
Terms explained
- Telomere
- Protective end of a chromosome.
- Marker
- A measurement that can change without a person improving.
Read the source and its limitations. A reference does not automatically validate a commercial product.
Read the source